The production of artemisinin, the most effective antimalarial compound, is limited to Artemisia annua. Enzymes involved in artemisinin biosynthesis include amorpha-4,11-diene synthase (ADS), amorpha-4,11-diene 12-monooxygenase (CYP71AV1) and artemisinic aldehyde Á(11)13 reductase (DBR2). Although artemisinin and its specific intermediates are not detected in other Artemisia species, we reported previously that CYP71AV1 and DBR2 homologs were expressed in some non-artemisinin-producing Artemisia plants. These homologous enzymes showed similar functions to their counterparts in A. annua and can convert fed intermediates into the following products along the artemisinin biosynthesis in planta. These findings suggested a partial artemisinin-producing ability in those species. In this study, we examined genes highly homologous to ADS, the first committed gene in the pathway, in 13 Artemisia species. We detected ADS homologs in A. absinthium, A. kurramensis and A. maritima. We analyzed the enzymatic functions of all of the ADS homologs after obtaining their cDNA. We found that the ADS homolog from A. absinthium exhibited novel activity in the cyclization of farnesyl pyrophosphate (FPP) to koidzumiol, a rare natural sesquiterpenoid. Those from A. kurramensis and A. maritima showed similar, but novel, activities in the cyclization of FPP to (+)-a-bisabolol. The unique functions of the novel sesquiterpene synthases highly homologous to ADS found in this study could provide insight into the molecular basis of the exceptional artemisininproducing ability in A. annua.
Introduction
Terpenoids are the largest group of natural compounds and have a wide range of bioactivities (Wang et al. 2005) . Terpenoid building blocks are derived from the condensation of C 5 isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate. The addition of IPP moieties elongates the building blocks into the common precursors geranyl pyrophosphate (C 10 ), farnesyl pyrophosphate (FPP, C 15 ) and geranylgeranyl pyrophosphate (C 20 ). These common precursors diverge into numerous terpenoids, which are classified based on size, including monoterpenoids (C 10 ), sesquiterpenoids (C 15 ), diterpenoids (C 20 ) and longer terpenoids, via the unique functions of various terpene synthases (Davis and Croteau 2000) . From this, the chemodiversity of terpenoids controlled by terpene synthases has led to the discovery of >67,000 different structures isolated from plants, animals and microbes (Chapman & Hall/CRC Chemical Database 2016) .
Among the highly diverse terpenoids, artemisinin, a sesquiterpene lactone isolated from the plant Artemisia annua, is one of the most renowned terpene-based drugs and is used as a standard treatment for malaria (World Health Organization 2015) . The first committed step in the biosynthesis of artemisinin is the cyclization of FPP to amorpha-4,11-diene by amorpha-4,11-diene synthase (ADS) (Chang et al. 2000) . Then, amorpha-4,11-diene 12-monooxygenase (CYP71AV1) catalyzes the multistep oxidation of amorpha-4,11-diene to artemisinic alcohol and artemisinic aldehyde (Teoh et al. 2006) , followed by a reduction to dihydroartemisinic aldehyde by artemisinic aldehyde Á11(13)-reductase (DBR2) (Zhang et al. 2008 ). Dihydroartemisinic aldehyde is oxidized and converted into artemisinin over several steps (Brown and Sy 2004, Teoh et al. 2009) (Fig. 1) .
Over 400 Artemisia species have been identified worldwide (The Plant List 2013); however, artemisinin is produced only in A. annua. Previous work in our laboratory isolated and extensively analyzed the profile of sesquiterpenoids in 31 Artemisia plants. Among these, however, we could not detect any traces of artemisinin or its specific intermediates from the extracts of Artemisia species other than A. annua (M. Suzuki et al. unpublished data) . To investigate the molecular basis of this exceptional artemisinin-producing ability in A. annua, therefore, we analyzed the expression of ADS, CYP71AV1 and DBR2 homologs in non-artemisinin-producing Artemisia species and reported previously that ADS homologs were not expressed in A. afra and A. absinthium. In contrast, we found the expressions of CYP71AV1 homolog in A. afra and both CYP71AV1 and DBR2 homologs in A. absinthium. Interestingly, all homologous enzymes showed similar functions to their corresponding enzymes in A. annua and converted the fed artemisinin intermediates into the following products until the last precursor of artemisinin in planta (Komori et al. 2013 , Muangphrom et al. 2014 . From these results, we hypothesized that the first cyclization step by ADS could be the key step controlling artemisinin biosynthetic capability in Artemisia plants.
In this study, we examined the presence of ADS homologs in 13 non-artemisinin-producing Artemisia species. The expression and enzymatic function of the present ADS homologs were then analyzed. Our investigation led to the discovery of two novel sesquiterpene synthases isolated from A. absinthium, A. kurramensis and A. maritima with unique catalytic activities in the synthesis of rare natural sesquiterpenoids. Our findings not only support our hypothesis, but also provide a hint that the acquisition of ADS may confer the exceptional artemisininproducing ability on A. annua.
Results
Expression of ADS homologs in non-artemisininproducing Artemisia plants Leaves of various Artemisia plants were collected, and genomic PCR (gPCR) was performed using primers specific to the fulllength sequence (from the start codon to the stop codon) of A. annua ADS to investigate the presence of ADS homologs. gPCR products of ADS homologs were detected in A. absinthium, A. kurramensis and A. maritima ( Fig. 2A) . Potential exons and introns of all ADS homologs were estimated from a comparison of their sequences with that of A. annua ADS. Their genomic structures contained seven potential exons and six potential introns (Table 1) , and showed >89% and 60% homology for all exons and introns, respectively, except for intron II, which exhibited a large difference in length ( Table 2) . Reverse transcription-PCR (RT-PCR) analysis revealed that these ADS homologs were expressed in A. kurramensis roots and in both leaves and roots of A. maritima, but not in A. absinthium (Fig. 2B) . Then, the ADS homologs from A. kurramensis roots and A. maritima Fig. 1 Biosynthetic pathways of artemisinin, koidzumiol (1) and (+)-a-bisabolol (2). The enzymes responsible for each reaction are indicated. The full names of each responsible enzyme are described in the text. The artemisinin biosynthetic pathway was adapted from Muangphrom et al. (2014) . The koidzumiol (1) and (+)-a-bisabolol (2) biosynthetic pathways were newly determined in this study.
leaves were cloned and sequenced. We found that both sequences were identical to the previous estimate from the corresponding genomic sequences and showed high homology (99% identity for cDNA; see Supplementary Table S1 for genomic DNA homology).
cDNA recovery by surrogate splicing Surrogate splicing (Wu et al. 2005 ) was performed to recover the full-length cDNA of the A. absinthium ADS homolog. To detect possible variations in the ADS homolog, we isolated genomic fragment of ADS homologs from two different strains RT-PCR analysis of the expressions of ADS and CYP71AV1 homologs in the leaves and roots of A. absinthium, A. kurramensis and A. maritima. The expression of ADS and CYP71AV1 in the leaves and roots of A. annua was used as a control. Actin was included as an internal control. of A. absinthium; strain 1 was obtained from Hoshi University and strain 2 was purchased from a local herb store. These intron-containing genes were artificially expressed under the control of the Cauliflower mosaic virus (CaMV) 35S promoter in stably transformed Arabidopsis thaliana. RT-PCR using RNA from T 2 transgenic plants resulted in the amplification of intron-less fragments of the ADS homolog of both A. absinthium strains (Fig. 3) . No variations in the ADS homologs were detected, as the sequences of the recovered cDNAs were identical, although their genomic sequences showed some differences in introns II, III and V (Supplementary Table S2 ).
Highly conserved motifs of sesquiterpene synthases in ADS homologs
The R(R,P)(X) 8 W, RXR, DDXXD and NSE/DTE motifs, which are conserved in terpene synthases (Tholl et al. 2005 , Christianson 2006 , Ee et al. 2014 , were present in all ADS homologs (Fig. 4) . Their RXR motif was identical. The R(R,P)(X) 8 W and NSE/DTE motifs of the homologous enzymes from A. kurramensis and A. maritima were identical, but differed from the others. The ADS homolog from A. absinthium differed by one amino acid, residue 301, in the DDXXD motif. Phylogenetic analysis showed that the ADS homologs from A. kurramensis and A. maritima were located within the same branch as A. annua a-bisabolol synthase (BOS), and shared the same node with A. annua ADS and the ADS homolog from A. absinthium (Fig. 5) . BLASTP analysis showed that the amino acid sequences of all ADS homologs were highly homologous to ADS and A. annua BOS (Supplementary Fig. S1 ; Supplementary Table S3 ). These results suggested that all ADS homologs may share the same catalytic mechanism with 1,6-ring closure as the first cyclization step as ADS and BOS.
Functional analysis of ADS homologs
Threonine (T) was the predominant amino acid residue (position 301 in the DDXXD motif) as compared with other amino acids ( Supplementary Fig. S1 ). Although this residue may not be a direct part of the divalent metal-binding site (Tarshis et al. 1996 , Hosfield et al. 2004 ), we were curious why only the ADS homolog from A. absinthium has serine (S) instead of the predominant T at this position ( Fig. 4 ; Supplementary Fig. S1 ). Thus, we generated the ADS homolog from A. absinthium with S301T mutation (S301T mutant) and included it in our experiment. To analyze the function of all ADS homologs, we performed in vitro enzymatic assays with FPP as a substrate. The results are shown in Fig. 6 and Supplementary Fig. S2 . Fig. 4 Amino acid sequence alignment of ADS, AabKOS, AkBOS and AmBOS. Conserved motifs of terpene synthases are underlined: R(R,P)(X) 8 W, purple; RXR, blue; DDXXD, red; NSE/DTE, green. The S301T mutation site is indicated by a red triangle. Black shading indicates completely conserved amino acid residues. Gray shading indicates amino acid residues with >51% conservation. Amorpha-4,11-diene and amorpha-4,7(11)-diene were detected as major and minor products in the reaction with ADS, respectively, similar to a previous report (Mercke et al. 2000) . The major products of the reactions with the ADS homologs differed in both retention time and mass fragmentation pattern from amorpha-4,11-diene. The cyclization of FPP catalyzed by the ADS homolog from A. absinthium produced compound 1 as a major product. The S301T mutant exhibited similar activity to the wild-type enzyme, as compound 1 was detected as its major product. However, the production yield of 1 from the mutant was 2.5-fold lower than that from the wild type. Enzymes from A. kurramensis and A. maritima exhibited the same activity, producing compound 2 as a major product.
We also analyzed the function of all ADS homologs in vivo by expressing each ADS homolog in the high FPP-producing Saccharomyces cerevisiae strain EPY300 (Ro et al. 2006 , Ro et al. 2008 . After extraction and analysis of the sesquiterpenoids produced in yeasts, similar results to in vitro enzymatic assays were obtained. Yeast expressing the ADS homolog from A. absinthium and the S301T mutant produced compound 1 as a major product, while those from A. kurramensis and A. maritima produced compound 2 as a major product ( Fig. 7 ; Supplementary Fig. S3 ). In addition, trace amounts of amorpha-4,11-diene, amorpha-4,7(11)-diene and compound 2 were detected in the extract of yeast expressing the S301T mutant (Fig. 7) . However, the production yield of 1 in this strain was 24-fold higher than that in yeast expressing the wild-type gene, in contrast to the results from the in vitro enzymatic assays. We hypothesized that this could be due to the different concentrations of Mg 2+ between the in vitro and in vivo assays, as it is crucial for complete enzymatic function (Aaron and Christianson 2010, Köksal et al. 2011) .
Structure determination of the products
To determine the structure of all detected products, compounds 1 and 2 were extracted from yeast expressing the S301T mutant and the ADS homolog from A. maritima, and purified by column chromatography. After purification, the productivities of 1 and 2 in yeast expressing the corresponding genes were about 12 and 83 mg l -1 , respectively. The purified compounds were analyzed by 1D-and 2D-nuclear magnetic resonance (NMR) spectroscopy, and the relative configurations were determined from the nuclear Overhauser effect spectroscopy (NOESY) spectrum. Compound 1 was determined to be a koidzumiol with S*, S*, R* and R* configurations at C-1, C-6, C-7 and C-10, respectively, the same as that reported previously from Artemisia koidzumii (Bohlmann and Zdero 1980) , a rare Artemisia plant discovered by Nakai (1911) (Supplementary Fig. S4 ; Supplementary Table  S4) ; therefore, we renamed the ADS homolog from A. absinthium koidzumiol synthase (AabKOS). Detailed information regarding structure elucidation and the correlation observed The rooted Neighbor-Joining tree was generated based on amino acid sequences of sesquiterpene synthases identified in Artemisia species using CLUSTAL W and MEGA7 software. The numbers indicate the bootstrap value (%) from 1,000 replications. Artemisia annua germacrene A synthase was used as the out-group. Black arrowheads correspond to enzymes cloned in this study. GenBank accession numbers are indicated in parentheses. The first cyclization mechanisms are indicated in square brackets. ADS, amorpha-4,11-diene synthase; KOS, koidzumiol synthase; BOS, a-bisabolol synthase; QHS, b-caryophyllene synthase; ECS, 8-epi-cedrol synthase; FS, (E)-b-farnesene synthase; GAS, germacrene A synthase.
Fig. 6
In vitro enzymatic assays of ADS, AabKOS, AabKOS S301T , AkBOS and AmBOS. Total ion chromatograms of the in vitro assay reaction products are shown. From the top, the chromatograms show the reaction with b-glucuronidase (GUS; negative control), ADS (positive control), AabKOS, AabKOS S301T , AkBOS, AmBOS and the amorpha-4,11-diene authentic standard, respectively. The black arrow indicates a peak of amorpha-4,7(11)-diene. The mass spectra of the detected amorpha-4,11-diene peaks were compared with the standard. Koidzumiol (1) was detected as a major product of AabKOS and AabKOS S301T . (+)-a-Bisabolol (2) was detected as a major product of AkBOS and AmBOS. The mass spectra of the major products in each reaction are shown in Supplementary Fig. S2 . Asterisks indicate minor peaks detected at the same retention time as amorpha-4,11-diene or (+)-a-bisabolol (2), with slightly different mass spectra (data not shown). from 2D-NMR spectra can be found in the Supplementary information.
The 1 H-and 13 C-NMR spectra of 2 matched well with those of the (-)-a-bisabolol standard (Supplementary Table S5 ), showing that compound 2 was not epi-a-bisabolol (Chen et al. 1993 , Hashidoko et al. 1994 , Attia et al. 2012 , Son et al. 2014 . The specific rotation obtained from this analysis was ½a +57.04 (MeOH) (Günther et al. 1993) . Therefore, compound 2 was determined to be (+)-a-bisabolol, and we renamed the ADS homologs from A. kurramensis and A. maritima (+)-abisabolol synthase (AkBOS and AmBOS, respectively).
Discussion
Sesquiterpene synthases are key enzymes that control the chemodiversity of sesquiterpenoids. Artemisinin, the most effective antimalarial drug and one of the most valuable sesquiterpenoids, is produced only in A. annua. Although homologous enzymes with similar functions to those in A. annua have been identified (CYP71AV1 homologs in A. afra and A. absinthium, and a DBR2 homolog in A. absinthium), and the partial pathway from the oxidation of amorpha-4,11-diene to the following products in artemisinin biosynthesis can be observed in planta (Komori et al. 2013 , Muangphrom et al. 2014 , ADS, the first committed gene in the pathway, was not expressed, and neither artemisinin nor its intermediates were detected. The cyclization of FPP to amorpha-4,11-diene seems to be a unique function of sesquiterpene synthase ADS and limits the artemisinin-producing ability to A. annua. Therefore, we searched for the presence of ADS homologs in 13 non-artemisinin-producing Artemisia species and cloned them for further functional analyses. Unlike ADS, these ADS homologs showed unique functions on the cyclization of FPP to the rare natural sesquiterpenoids: koidzumiol (1) and (+)-abisabolol (2).
Among the 13 species of non-artemisinin-producing Artemisia plants, ADS homologs were found only in three species: A. absinthium, A. kurramensis and A. maritima ( Fig. 2A) . Although it is possible that the sequence of ADS homologs in other Artemisia plants may differ and showed no bands after amplification with primers based on the full-length A. annua ADS, the results suggest that the inability to produce artemisinin in 10 of the examined Artemisia plants could be due to a lack of this key gene. Still further studies are required to confirm the absence of ADS homologs in these Artemisia species.
The expression analysis in this study showed similar results to those which previously reported that A. annua ADS was expressed in leaves, but not in roots (Ma et al. 2009 , Oloffson et al. 2011 , Pu et al. 2013 . In contrast, the ADS homolog from A. kurramensis was expressed only in roots (Fig. 2B) . In A. maritima, the expression of this homologous gene was higher in roots than in leaves (Fig. 2B) . In A. absinthium, the expression of the ADS homolog was not detected, similar to a previous report (Komori et al. 2013) . Therefore, it was artificially expressed under the control of the CaMV 35S promoter in transgenic Arabidopsis thaliana, and we successfully obtained intron-less fragments of A. absinthium ADS homologs via surrogate splicing (Fig. 3) .
Four stereoisomers of a-bisabolol are found in nature, each of which can be isolated from different plants (Jequier et al. 1980 , Matos et al. 1988 , Günther et al. 1993 , Hashidoko et al. 1994 , Hashidoko et al. 2000 . The enzymes responsible for cyclization of FPP to (+)-epi-a-bisabolol, (-)-a-bisabolol and (-)-epi-a-bisabolol have been isolated previously from Lippia dulcis, Matricaria recutita and Streptomyces citricolor, respectively (Nakano et al. 2011 , Attia et al. 2012 , Son et al. 2014 ). However, the enzyme synthesizing (+)-a-bisabolol has not been identified. In this study, based on both the polarimetric and spectroscopic data, we verified (+)-a-bisabolol synthase from A. kurramensis (AkBOS) and A. maritima (AmBOS). Both AkBOS and AmBOS showed strict enantioselectivity and high product specificity, as only (+)-a-bisabolol (2) was detected as a major product (Figs. 6, 7) . De novo synthesis of Fig. 7 In vivo enzymatic assays of ADS, AabKOS, AabKOS S301T , AkBOS and AmBOS. Total ion chromatograms of in vivo assay products are shown. From the top, the chromatograms show the extracts of yeast expressing an empty vector (negative control), ADS (positive control), AabKOS, AabKOS S301T , AkBOS, AmBOS and the amorpha-4,11-diene authentic standard, respectively. The black arrows indicate the amorpha-4,7(11)-diene peak. Koidzumiol (1) was detected as a major product in the extracts of yeast expressing AabKOS or AabKOS S301T . (+)-a-Bisabolol (2) was detected as a major product in the extracts of yeast expressing AkBOS or AmBOS. Amorpha-4,11-diene, amorpha-4,7(11)-diene and (+)-a-bisabolol (2) were also detected as minor products in the extracts of yeast expressing AabKOS S301T . The mass spectra of the products detected in each extract are shown in Supplementary Fig. S3. this compound by the expression of AkBOS or AmBOS in the EPY300 background of yeast, developed to elevate FPP production (Ro et al. 2006 , Ro et al. 2008 , resulted in high production (up to approximately 83 mg l -1 ). Therefore, this is the first report of (+)-a-bisabolol synthase that can be used for the de novo production of enantio-pure (+)-a-bisabolol (2) in a yeast expression system.
The rare natural sesquiterpenoid koidzumiol (1) was synthesized by koidzumiol synthase from A. absinthium (AabKOS) (Figs. 6, 7) . In nature, this compound can be isolated from the aerial parts of A. koidzumii (Bohlmann and Zdero 1980) . However, neither its biosynthetic pathway nor its bioactivity has been reported, and it remains unknown why AabKOS is not expressed in A. absinthium. Although koidzumiol (1) has the same core skeleton as some bioactive natural compounds isolated from plants and marine organisms (bicyclo[4.3.1]dec-2-ene) (Cimino et al. 1975 , Schulte et al. 1980 , Goldring and Paden 2011 , the entirely different modification of their chemical structures suggests that they may be biosynthesized via different pathways and may exhibit different bioactivities. Therefore, future research will focus on the synthesis of koidzumiol derivatives and pharmacological evaluation of those derivatives, as they could be novel sesquiterpenoids with remarkable bioactivities.
In addition to koidzumiol (1), trace amounts of amorpha-4,11-diene, amorpha-4,7(11)-diene and (+)-a-bisabolol (2) were detected in the extract of yeast expressing AabKOS S301T (Fig. 7) . Although peaks with the same retention time were detected in products from the in vitro assays (Fig. 6 , shown by asterisks), they exhibited different mass spectra compared with the corresponding compounds (data not shown). Their quantities in the samples may have been too low, resulting in overlaps between their mass spectra and that of the background. Based on the presence of these minor product peaks in vivo, koidzumiol (1) cyclization may share the same pathway as amorpha-4,11-diene, amorpha-4,7(11)-diene and (+)-a-bisabolol (2). The cyclization mechanism of amorpha-4,11-diene was reported previously (Kim et al. 2006) . Therefore, we incorporated our results into the pathway and proposed the plausible cyclization mechanism as shown in Fig. 8 .
As rare sesquiterpenoids, further studies on the production of koidzumiol and (+)-a-bisabolol derivatives may lead to the synthesis of novel sesquiterpenoids with promising bioactivities. Interestingly, the expression of the CYP71AV1 homologs AabCYP71AV1 AkCYP71AV1 and AmCYP71AV1 was also detected in A. absinthium, A. kurramensis and A. maritima, respectively (Fig. 2B) . Komori et al. (2013) reported previously that AabCYP71AV1 oxidized amorpha-4,11-diene not only to artemisinic alcohol but also to its isomer, unlike A. annua CYP71AV1. This provides an interesting dimension to the synthesis of koidzumiol and (+)-a-bisabolol derivatives via the combination of either koidzumiol synthase or (+)-a-bisabolol synthase with the CYP71AV1 homologs found in this study.
Artemisinin is a unique compound produced only in A. annua. Although some reports have suggested that artemisinin may be produced as a defense against oxidative stress (Liu et al. 2002 , Qian et al. 2007 , Rai et al. 2011 , Li et al. 2012 or may act as an antifeedant to protect plants from herbivorous insects (Maggi et al. 2005) , the actual function of artemisinin in planta and the reason why artemisinin is produced only in A. annua remain unclear (Jessing et al. 2014) . Artemisia spp. first appeared in the late Eocene (Miao et al. 2011 ) and became more widely distributed in the early Miocene, with major radiations occurring in the late Miocene (Sanz et al. 2011) . The divergence of A. annua and A. absinthium appears to have begun during the middle Miocene (Sanz et al. 2008 , Sanz et al. 2011 . The split of A. annua from other Artemisia spp. was completed in the Pliocene (Sanz et al. 2011) . Although information regarding the evolution of Artemisia is limited, and the evolution of most of the Artemisia species analyzed in this study has not been examined, we can speculate that A. annua may have evolved and developed its artemisinin-producing ability as a response to environmental conditions for an as yet unknown role almost 5 million years ago. In addition, the emergence of ADS appears to be a recent occurrence after the appearance of other sesquiterpene synthases as a key enzyme in this exceptional process in A. annua (Fig. 5) . Therefore, further studies on the differences in environmental conditions with regard to the distribution of Artemisia spp. since their first appearance could provide clues on the role of artemisinin in planta.
We reported previously that CYP71AV1 and DBR2 homologs, with similar functions to their corresponding enzymes in A. annua, were present in some non-artemisinin-producing Artemisia plants and partially catalyze the pathway of artemisinin biosynthesis (Komori et al. 2013 , Muangphrom et al. 2014 . In this study, we examined the possible existence of ADS homologs in 13 non-artemisinin-producing Artemisia species and showed that the key gene, ADS, catalyzing the first step cyclization of FPP in the pathway, was not detected in most of the Artemisia species. Although further studies are required to verify the existence of ADS homologs in other Artemisia species, we discovered two novel sesquiterpene synthases highly homologous to ADS from A. absinthium, A. kurramensis and A. maritima, exhibiting unique functions which differed from that of ADS as koidzumiol and (+)-a-bisabolol synthases. Therefore, our findings supported the hypothesis that the exceptional artemisinin-producing ability of A. annua may be attributed by the acquisition of ADS
Materials and Methods

Plant materials
A. annua seeds were obtained from the Research Center for Medical Plant Resources, Natural Institute of Biomedical Innovation, Tsukuba, Japan. A. afra seeds were obtained from the University of Pretoria, Pretoria, South Africa. A. absinthium strain 1 was obtained from Hoshi University, Tokyo, Japan, and strain 2 was purchased from a local herb store in Japan. A. abrotanum, A. ludoviciana and A. princeps were provided by Ocean Expo Park, Okinawa, Japan. A. campestris and A. capillaris were obtained from the Health Sciences University of Hokkaido, Hokkaido, Japan. A. chamaemelifolia and A. kurramensis were provided by Nippon Shinyaku Co., Ltd., Kyoto, Japan. A. japonica was obtained from Showa Pharmaceutical University, Tokyo, Japan. A. maritima was obtained from Hoshi University, Tokyo, Japan. A. schmidtiana and A. vulgaris were purchased from local herb stores in Japan. The seeds of A. annua, A. afra and A. absinthium were germinated and grown in soil in an environment-controlled growth room at 22 C under an 18 h light/6 h dark cycle. All collected tissues were frozen and stored at -80 C until use.
Chemicals
FPP was purchased as the trans,trans-farnesyl pyrophosphate ammonium salt from Sigma-Aldrich. (-)-a-Bisabolol was also purchased from Sigma-Aldrich. Amorpha-4,11-diene was synthesized from artemisinic acid as described previously (Muangphrom et al. 2014 ).
General chemical analyses
Optical rotation was determined using a JASCO P-1020 polarimeter using a 50 mm microcell (1 ml).
1 H-and 13 C-NMR spectra were recorded using a JEOL JNM-ECS400 NMR spectrometer ( 1 H, 400 MHz; 13 C, 100 MHz). Chemical shifts were reported as d (ppm) relative to internal tetramethylsilane (d = 0 ppm). Gas chromatography-mass spectrometry (GC-MS) analysis was performed using a JMS-AM SUN200 mass spectrometer (JEOL) connected to a gas chromatograph (6890A, Agilent Technologies) and an HP-5MS capillary column (30 mÂ0.25 mm i.d., film thickness 0.25 mm; J&W Scientific) with a fused silica capillary tube (1 mÂ0.25 mm i.d., GL-Sciences). The HP-5MS capillary column was programmed to increase from 60 to 280 C at a rate of 3 C min -1 , followed by holding at 280 C for 400 s. The injection port temperature was set to 250 C. The ion source temperature was maintained at 250 C. The interface temperature was 280 C. The carrier gas was He at a flow rate of 0.7 ml min -1
. Split injection (1 ml) was conducted at a ratio of 1:10. The scanning speed of the mass spectrometer was 2 scans s -1 from m/z 40 to 350 at an electron voltage of 70 eV. The peak for amorpha-4,11-diene was identified by comparing the GC retention time and mass spectrum with those of the authentic standard. The peak for amorpha-4,7(11)-diene was identified by comparing the GC retention index and mass spectrum with those of previous reports (Weyerstahl et al. 1997, Joulain and König 1998) . Other product peaks detected in this experiment were purified, and their structures were identified using NMR spectroscopy.
Genomic DNA extraction
Genomic DNAs were extracted from leaves of Artemisia plants using a DNeasy Plant Mini Kit (Qiagen KK) according to the manufacturer's instructions. PCR was performed using primers 1 and 2 (Supplementary Table S6 ), which were designed based on the full-length coding sequence of A. annua ADS retrieved from GenBank (accession No. AF327527.1). The amplified products were cloned into pENTR/D-TOPO (Invitrogen) and sequenced.
RT-PCR and cDNA isolation
Total RNA was extracted from the leaves and roots of A. annua, A. absinthium, A. kurramensis and A. maritima using RNAiso Plus (TAKARA BIO INC.) and treated with RNase-free DNase (TAKARA BIO INC.). The RNA was purified further with an RNeasy Plant Mini Kit (Qiagen KK). First-strand cDNA was Fig. 8 A plausible biosynthetic mechanism of amorpha-4,11-diene, koidzumiol (1) and (+)-a-bisabolol (2) from FPP. The mechanism was modified from a previous report by Kim et al. (2006) . Elimination and re-addition of pyrophosphate (OPP) leads to the isomerization of FPP from transoid to cisoid. After the 1,6-ring closure of the cisoid cation yielding the bisabolyl cation, it can be hydroxylated to (+)-a-bisabolol (2). If a 1,3-hydride shift and 1,10-ring closure occur, the bisabolyl cation is cyclized to the 4-amorphenyl cation, which is further converted into amorpha-4,11-diene (route a). Alternatively, a 1,2-hydride shift may occur (route b) and lead to the generation of amorpha-4,7(11)-diene via proton elimination (route c) or the generation of a cyclopropyl intermediate via either proton elimination and ring formation (route d) or cyclization (route e). To reduce the steric effect from the cyclopropyl group in the structure, ring opening may occur as a reverse reaction of route e back to the tertiary carbocation intermediate. Alternatively, ring expansion may occur (route f), leading to the generation of secondary carbocation at C-6 which can be hydroxylated to koidzumiol (1).
synthesized using a PrimeScript RT-PCR Kit (TAKARA BIO INC.) with 1 mg of total RNA as a template. PCR was performed using primers 1 and 2 for ADS, 3 and 4 for CYP71AV1, and 5 and 6 for actin (internal control) (Olofsson et al. 2011) . The sequences of all primers used are listed in Supplementary Table S6 .
To obtain the full-length open reading frames (ORFs) encoding ADS, AkBOS, and AmBOS, RT-PCR was performed using primers 1 and 2. Thermal cycling conditions were as follows: 98 C for 2 min, followed by 35 cycles of 98 C for 10 s, 55 C for 15 s and 72 C for 30 s, and one cycle of 72 C for 10 min. The amplified product was cloned into pENTR/D-TOPO and sequenced.
Recovery of AabKOS cDNA by surrogate splicing
The genomic DNAs of AabKOS were transferred via the Gateway entry vector pENTR/D-TOPO into the Gateway-modified version of pRI101-AN binary vector (TAKARA BIO INC.) using Gateway LR Clonase II Enzyme Mix (Invitrogen) following the manufacturer's instructions. The vector pRI-101-AabKOS, in which the expression of AabKOS is controlled by the CaMV 35S promoter, was introduced into Agrobacterium tumefaciens GV3101 (pMP 90). Transformations of Arabidopsis thaliana (Col-0) were performed using the floral dip method as described by Zhang et al. (2006) using Agrobacterium tumefaciens harboring pRI-101-AabKOS. Then, total RNA was extracted from T 2 transgenic plants and purified following the method described above. After synthesizing the first-strand cDNA, RT-PCR was performed using primers 1 and 2 to obtain the full-length ORF encoding AabKOS, which was cloned into pENTR/D-TOPO and sequenced.
AabKOS mutagenesis
Mutagenesis of AabKOS was performed with inverse PCR amplification of the entire circular plasmid (AabKOS entry clone) with mutagenic primers 7 and 8. The PCR product was treated with Dpn I to digest methylated parental strands before transformation into Escherichia coli. After preparing plasmid DNA from the obtained colonies, the AabKOS coding region was fully sequenced to verify the success of generating AabKOS S301T without other undesired mutations.
Phylogenetic analysis
The alignment was performed using CLUSTALW (Thompson et al. 1994) with a gap open cost of 10 and gap extension cost of 0.2. The phylogenetic tree was constructed in MEGA7 software (Kumar et al. 2016 ) using the NeighborJoining method (Saitou and Nei 1987) with bootstrap analysis of 1,000 replicates. A. annua germacrene A synthase was used as the out-group.
Heterologous expression and in vitro enzymatic assays
The full-length ORFs encoding ADS, AabKOS, AabKOS S301T , AkBOS, and AmBOS were transferred via pENTR/D-TOPO into pDEST17 (Invitrogen) using Gateway LR Clonase II Enzyme Mix. Each expression clone was introduced into E. coli BL21-CodonPlus (DE3)-RIL (Agilent Technologies). After culturing in LB Miller medium containing ampicillin and chloramphenicol as selection markers and growing at 37 C with shaking at 170 rpm to an OD 600 of 0.4, they were incubated at 15 C for 30 min, followed by induction with isopropylb-D-1-thiogalactopyranoside (IPTG; final concentration, 1 mM). Then, cultures were incubated at 15 C with shaking at 160 rpm for 24 h. Protein extraction was performed as described by Muangphrom et al. (2014) , with minor modifications to the buffer components (Supplementary Table S7 ).
The in vitro enzymatic assays were initiated by adding FPP (final concentration, 100 mM) to the desalting buffer (Supplementary Table S7 ) containing 2 mg of purified protein. The mixtures were incubated at 30 C with shaking at 700 rpm for 2 h before stopping the reactions with 200 ml of 0.1 M EDTA in 0.2 M KOH, followed by extraction using 400 ml of EtOAc for GC-MS analysis. Reactions with ADS was used as a positive control, and with b-glucuronidase (GUS) was used as a negative control.
In vivo enzymatic assays
The full-length ORFs encoding ADS, AabKOS, AabKOS S301T , AkBOS, and AmBOS were transferred via pENTR/D-TOPO into pYES-DEST52 (Invitrogen) using Gateway LR Clonase II Enzyme Mix. Each expression clone was introduced into the S. cerevisiae strain EPY300 (Ro et al. 2006 , Ro et al. 2008 . Yeast harboring the pYES2/CT empty vector (Invitrogen) was used as a negative control. Transgenic yeast cells were cultured in synthetic complete medium (2 ml) containing 2% glucose without histidine, methionine and uracil (SC-His-Met-Ura) at 30 C 170 rpm for 1 d. Then, the cultures were added to SC-His-Met-Ura (50 ml) containing 1.8% galactose, 0.2% glucose and 1 mM methionine, and cultured at 30 C 170 rpm for 4 d. The resulting culture samples were disrupted by sonication at room temperature for 30 min and extracted three times with EtOAc. After washing the combined organic layer with brine and drying over anhydrous sodium sulfate, the samples were concentrated under reduced pressure and flow of nitrogen gas before further purification and GC-MS analysis.
Purification and structure determination of the products Koidzumiol (1). Crude extract (428.69 mg) of yeast expressing AabKOS S301T (1 liter culture) was subjected to silica gel column chromatography 60N (spherical, neutral, particle size 63-210 mm, Kanto Chemical Industry) and eluted with EtOAc-hexane (0-10%) to yield fractions A1-A4 after combination and removal of solvents. Fraction A2 (55.78 mg) was further purified with column chromatography (silica gel, 0-5% EtOAc-hexane as the eluent), yielding koidzumiol (12.07 mg) as a colorless oil. ½a 
